| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 15.14% | $346M | 16M | Fairmount Funds Management LLC | Oct 23, 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 4.5% | $42.2M | 3.58M | Venrock Healthcare Capital Partners III, L.P. | Dec 31, 2024 | |||
| Commodore Capital LP | 3.9% | -28% | $69.1M | -$23.7M | 3.2M | -25.6% | Commodore Capital LP | Sep 30, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 93.2M | $2.01B | -$25M | $21.58 | 166 |
| 2025 Q2 | 94.6M | $1.32B | +$45M | $13.98 | 169 |
| 2025 Q1 | 91.4M | $1.23B | -$2.45M | $13.48 | 174 |
| 2024 Q4 | 91M | $1.75B | +$57.7M | $19.17 | 177 |
| 2024 Q3 | 86.9M | $1.98B | +$415M | $22.75 | 165 |
| 2024 Q2 | 69.5M | $904M | -$23.1M | $13.01 | 137 |
| 2024 Q1 | 71M | $1.24B | +$176M | $17.51 | 135 |
| 2023 Q4 | 23.3K | $507K | -$810K | $21.78 | 2 |
| 2023 Q3 | 50.2M | $770M | +$30.5M | $15.34 | 122 |
| 2023 Q2 | 47.1M | $1.12B | +$92.6M | $23.79 | 127 |
| 2023 Q1 | 43.1M | $1.1B | +$41M | $25.44 | 134 |
| 2022 Q4 | 40.9M | $1.19B | +$88.2M | $29.21 | 119 |
| 2022 Q3 | 37.8M | $775M | +$210M | $20.51 | 101 |
| 2022 Q2 | 28.2M | $327M | +$27.4M | $11.57 | 76 |
| 2022 Q1 | 24.9M | $461M | +$26.5M | $18.49 | 71 |
| 2021 Q4 | 23.3M | $460M | +$113M | $19.77 | 52 |
| 2021 Q3 | 13.6M | $224M | +$123M | $16.45 | 38 |
| 2021 Q2 | 6M | $110M | +$18.4M | $18.29 | 24 |
| 2021 Q1 | 5.09M | $84.5M | +$80.7M | $16.71 | 29 |
| 2020 Q4 | 229K | $3.77M | +$3.77M | $16.46 | 2 |